| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
53,543,000 |
| Market
Cap: |
11.50(B) |
| Last
Volume: |
464,634 |
Avg
Vol: |
475,567 |
| 52
Week Range: |
$164.52 - $273.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 456 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
| Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
5 |
| Total Shares Sold |
1,636 |
31,084 |
49,996 |
92,833 |
| Total Sell Value |
$374,194 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
| Total People Sold |
2 |
6 |
6 |
8 |
| Total Sell Transactions |
2 |
11 |
16 |
28 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-03-05 |
4 |
OE |
$73.70 |
$1,278,677 |
D/D |
12,467 |
30,201 |
|
- |
|
| Andrews Nancy C |
Director |
• • – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
124 |
124 |
|
- |
|
| Chubb Stephen D |
Director |
• • – |
2020-02-27 |
4 |
S |
$160.89 |
$396,437 |
D/D |
(2,464) |
39,541 |
|
-17% |
|
| Chubb Stephen D |
Director |
• • – |
2020-02-27 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
42,005 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-26 |
4 |
AS |
$160.45 |
$679,535 |
D/D |
(4,188) |
20,475 |
|
8% |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-26 |
4 |
OE |
$73.70 |
$308,656 |
D/D |
4,188 |
24,663 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-26 |
4 |
AS |
$160.40 |
$4,076,411 |
D/D |
(25,124) |
286,775 |
|
8% |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-26 |
4 |
OE |
$73.70 |
$1,851,639 |
D/D |
25,124 |
311,899 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-02-26 |
4 |
D |
$162.46 |
$44,352 |
D/D |
(273) |
17,734 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-26 |
4 |
D |
$162.46 |
$368,947 |
D/D |
(2,271) |
286,775 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-26 |
4 |
D |
$162.46 |
$61,572 |
D/D |
(379) |
20,475 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-02-26 |
4 |
D |
$162.46 |
$49,225 |
D/D |
(303) |
19,055 |
|
- |
|
| Johst David P |
Corporate Executive VP |
• • – |
2020-02-26 |
4 |
D |
$162.46 |
$118,108 |
D/D |
(727) |
223,921 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-02-26 |
4 |
D |
$162.46 |
$24,694 |
D/D |
(152) |
22,617 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-24 |
4 |
D |
$173.64 |
$383,744 |
D/D |
(2,210) |
289,046 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-24 |
4 |
AS |
$167.83 |
$503,490 |
I/I |
(3,000) |
2,250 |
|
6% |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-24 |
4 |
AS |
$166.51 |
$7,385,433 |
D/D |
(44,303) |
289,046 |
|
6% |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-24 |
4 |
OE |
$88.05 |
$4,332,960 |
D/D |
44,303 |
333,349 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-24 |
4 |
AS |
$166.53 |
$1,368,953 |
D/D |
(8,211) |
20,854 |
|
6% |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-24 |
4 |
OE |
$88.05 |
$804,860 |
D/D |
8,211 |
29,065 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-24 |
4 |
D |
$173.64 |
$69,803 |
D/D |
(402) |
20,854 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-02-24 |
4 |
D |
$173.64 |
$55,912 |
D/D |
(322) |
18,007 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-02-24 |
4 |
D |
$173.64 |
$55,912 |
D/D |
(322) |
22,769 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-02-24 |
4 |
D |
$173.64 |
$55,912 |
D/D |
(322) |
19,358 |
|
- |
|
| Johst David P |
Corporate Executive VP |
• • – |
2020-02-24 |
4 |
D |
$173.64 |
$123,284 |
D/D |
(710) |
224,648 |
|
- |
|
2069 Records found
|
|
Page 20 of 83 |
|
|
6.83 (3.08%) 
